参附注射液治疗急性下壁心肌梗死并低血压临床观察

The Clinical Observation of Shenfu Injection on Hypotension Due to Acute Inferior Myocardial Infarction

目的 :评价参附注射液治疗急性下壁心肌梗死合并低血压状态病人疗效及安全性。方法 :总结我院 2 0 0 1年 10月— 2 0 0 3年 1月急性下壁心肌梗死合并低血压状态病人 5 0例 ,其中参附组 (治疗组 ) 2 5例 ,多巴胺组 (对照组 ) 2 5例 ,观察其临床疗效。结果 :两组用药后血压回升明显。治疗组升压总有效率为 10 0 % ,对照组升压总有效率为76% ,治疗组未见不良反应 ,对照组发生心律失常率为 40 %。结论 :参附注射液在治疗急性下壁心肌梗死合并低血压状态效果明显 ,无副反应发生。

Objective:To evaluate the effects of Shenfu injection on hypotension due to acute inferior myocardial infarction. Methods:Fifty patients from October 2001 to January 2003 were randomly divided into Shenfu group and dopamine (control) group (25 patients in each group). Results:The effective rate were 100% vs 76% in Shenfu and control groups, respectively(P<0.01). There were no complications in Shenfu group but 40% arrhythmias in controls. Conclusions:Shenfu injection could improve the effect of hypotension due to acute inferior myocardial infarction without complications.